Skip Navigation


Annals of Oncology Advance Access originally published online on March 12, 2009
Annals of Oncology 2009 20(5):961-962; doi:10.1093/annonc/mdp041
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/5/961    most recent
mdp041v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bandieri, E.
Right arrow Articles by Ripamonti, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bandieri, E.
Right arrow Articles by Ripamonti, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letters to the editor

Prescription of opioids in Italy: everything, but the morphine

The first 10% of the full text of this article appears below.

Oral morphine remains the drug of choice for moderate or severe cancer pain and an important indicator of progress in cancer pain management, according to international guidelines and Cochrane systematic review [1–4]. The available data on the consumption of opioids, particularly of morphine, in Europe apparently show an inappropriate trend . . . [Full Text of this Article]

E. Bandieri1, A. Chiarolanza1, M. Luppi2, N. Magrini1, A. M. Marata1,{dagger} and C. Ripamonti3,{dagger},*

1 Centre for the Evaluation of the Effectiveness of Health Care (CeVEAS), WHO Collaborating Centre
2 Department of Oncology, Haematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena
3 Palliative Care Unit (Pain Therapy and Rehabilitation), National Cancer Institute, Milan, Italy

* (E-mail: carla.ripamonti@istitutotumori.mi.it)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
D. Errante, C. De Chirico, and L. Salvagno
Comment on 'Older cancer patients in an Italian hospice'
Ann. Onc., June 1, 2009; 20(6): 1146 - 1147.
[Full Text] [PDF]